Loading...
OTC Markets
Totals
Securities
12,261
Dollar Vol
$2.5B
Share Vol
5.1B
Trades
356,399

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

NNLX
Nanologix, Inc.

Common Stock
Nanologix, Inc. Company Logo

843 North Main Street

Hubbard, OH 44425

Business Description
Research, development, commercialization, and production of filled Petri plates and rapid diagnostic test kits.
Financial Reporting
Reporting Status
Dark: Alternative Reporting Standard
Audited Financials
Not Available
Latest Report
Not Available
CIK
0001030065
Fiscal Year End
12/31
Company Officers & Contacts
Bret A. Barnhizer
CEO, President

Daniel Barnhizer
Esq.

Carol Surena
Corporate Secretary

Joshua Barnhizer
Corporate Counsel

Board of Directors
Bret A. Barnhizer
Chairman, CEO, President

Daniel Barnhizer

John Chatterton

Jeff Long

Other Company Insiders

Not available

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Securities Counsel
Arnold & Porter

777 South Figueroa Street

44th Floor

Los Angeles, CA 90017

Profile Data
SIC - Industry Classification
8731 - Commercial physical research
Incorporation Information
DE, US, 1989
Employees
11 as of 06/01/2012
Shell
No
Products and Services

Not available

Company Facilities

Not available

Company Notes
Formerly=Infectech, Inc. until 5-05
Note=6-00 company is in the development stage, researching & developing diagnostic tests for infectious human diseases
Expert Market Icon
This market serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing.
Expert Market
OTC Markets Group is unable to confirm this company is providing public disclosure to a regulator, an exchange, or OTC Markets Group.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.